Skip to main content

Table 3 Genotype frequency of hOGG1 Ser326Cys in patients with oesophageal cancer

From: 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker of oxidative damage in oesophageal cancer patients: lack of association with antioxidant vitamins and polymorphism of hOGG1 and GST

Genotype

Controls (n = 43)

(%)

Patients (n = 17)

(%)

Total (n = 60)

(%)

Ser/Ser

22 (51)

14 (82)

36 (60)

Ser/Cys

19 (44)

3 (18)

22 (37)

Cys/Cys

2 (5)

0

2 (3)

Cys allele frequency

0.27

0.09

0.22

  1. Numbers in parentheses represent the relative percentage in the group.